Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases

PaperCitations, authors & open-access status

Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 105 citations, 2017 year and bronze oa status.

105
Citations
2017
Year
bronze
OA Status

Related on ScholarIQ

Dejan Micić
Author
Alimentary Pharmacology & Therapeutics
Journal
Biosimilars and Bioanalytical Methods
Topic
Biosimilars and Bioanalytical Methods
Topic
Inflammatory Bowel Disease
Topic
Microscopic Colitis
Topic
470M+ articles · free account